全文获取类型
收费全文 | 4354篇 |
免费 | 200篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 121篇 |
妇产科学 | 59篇 |
基础医学 | 555篇 |
口腔科学 | 143篇 |
临床医学 | 457篇 |
内科学 | 974篇 |
皮肤病学 | 61篇 |
神经病学 | 280篇 |
特种医学 | 517篇 |
外科学 | 687篇 |
综合类 | 47篇 |
预防医学 | 211篇 |
眼科学 | 106篇 |
药学 | 173篇 |
中国医学 | 9篇 |
肿瘤学 | 199篇 |
出版年
2021年 | 46篇 |
2020年 | 30篇 |
2019年 | 43篇 |
2018年 | 58篇 |
2017年 | 38篇 |
2016年 | 54篇 |
2015年 | 56篇 |
2014年 | 96篇 |
2013年 | 117篇 |
2012年 | 138篇 |
2011年 | 134篇 |
2010年 | 105篇 |
2009年 | 122篇 |
2008年 | 149篇 |
2007年 | 152篇 |
2006年 | 137篇 |
2005年 | 160篇 |
2004年 | 120篇 |
2003年 | 130篇 |
2002年 | 165篇 |
2001年 | 153篇 |
2000年 | 150篇 |
1999年 | 153篇 |
1998年 | 135篇 |
1997年 | 112篇 |
1996年 | 92篇 |
1995年 | 77篇 |
1994年 | 70篇 |
1993年 | 65篇 |
1992年 | 94篇 |
1991年 | 82篇 |
1990年 | 77篇 |
1989年 | 87篇 |
1988年 | 95篇 |
1987年 | 77篇 |
1986年 | 76篇 |
1985年 | 69篇 |
1984年 | 54篇 |
1983年 | 40篇 |
1982年 | 40篇 |
1981年 | 35篇 |
1979年 | 40篇 |
1978年 | 31篇 |
1977年 | 35篇 |
1976年 | 28篇 |
1975年 | 34篇 |
1973年 | 23篇 |
1969年 | 25篇 |
1968年 | 25篇 |
1967年 | 24篇 |
排序方式: 共有4636条查询结果,搜索用时 218 毫秒
81.
82.
Thomas Lehrnbecher Andreas Trusen Frank Deinlein Burkhard Hcht Alexander Marx Joachim Kühl 《Pediatric blood & cancer》2003,40(1):13-17
Lymphoproliferative disorder (LPD) is described in only a few children receiving chemotherapy for cancer. In all of them, an association between LPD and EBV (Epstein‐Barr Virus) was found. We report on a patient who developed LPD not associated with EBV while receiving chemotherapy for relapsed acute lymphoblastic leukemia (ALL). Despite discontinuation of chemotherapy, administration of intravenous immunoglobulins and surgery the patient died. Growing experience with this disorder may allow better treatment options in the future and will show whether LPD not associated with EBV requires different therapeutic strategies. Med Pediatr Oncol 2003;40:13–17, © 2003 Wiley‐Liss, Inc. 相似文献
83.
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. 总被引:14,自引:0,他引:14
Philipp Str?bel Andrea Bauer Bernhard Puppe Til Kraushaar Axel Krein Klaus Toyka Ralf Gold Michael Semik Reinhard Kiefer Wilfred Nix Berthold Schalke Hans Konrad Müller-Hermelink Alexander Marx 《Journal of clinical oncology》2004,22(8):1501-1509
PURPOSE: Thymic epithelial tumors (TET) are rare epithelial neoplasms of the thymus with considerable histologic heterogeneity. This retrospective study focused on the correlation of WHO-defined TET histotypes with survival and tumor recurrence in a large cohort of patients receiving different modes of treatment. PATIENTS AND METHODS: Two hundred twenty-eight patients were followed for up to 21 years (median, 60 months; range, 1 to 252 months) after primary surgery. Forty-two patients received adjuvant radiotherapy (mean dose, 53 Gy), and 33 patients received adjuvant chemotherapy. RESULTS: Seventy-six (88%) of 86 patients with WHO type A, AB, and B1 thymomas were treated by surgery alone, with three tumor relapses after 3 to 10 years (median, 3.4 years). Twelve of 67 patients with WHO type B2 and B3 thymomas in Masaoka stages I and II were treated by adjuvant radiotherapy without evidence of tumor recurrence after 1 to 12 years (median, 4 years). Among 75 patients with B2 and B3 thymomas with incomplete resection or a tumor stage III or higher, the recurrence rate was 34% (n = 23) after 0.5 to 17 years (median, 5 years) in patients receiving adjuvant radiochemotherapy, compared to 78% (seven of nine patients) in patients without adjuvant radiochemotherapy. Incomplete tumor resection was associated with a high recurrence rate (65%) and a poor prognosis (P <.01). CONCLUSION: The long-term outcome of TET patients is related to tumor stage, WHO histotype, completeness of surgical removal, and type of treatment. Prospective trials are warranted to formally address the efficacy of adjuvant therapy in the treatment of localized and advanced malignant TETs. 相似文献
84.
85.
Zhang WJ Marx SK Laue C Hyder A Juergensen A Bickel M Schrezenmeir J 《Transplantation proceedings》2000,32(1):206-209
86.
87.
J VALENTINE E ROSSI P O'LEARY TS PARRY JJ KURINCZUK P SLY 《Journal of paediatrics and child health》1997,33(2):117-120
To determine the prevalence of thyroid hormone abnormalities and generalized resistance to thyroid hormone in a population of children with attention deficit hyperactivity disorder (ADHD) as compared to reference ranges determined from a control population and hence to determine if routine thyroid hormone screening in children with non-familial ADHD is indicated.
Children attending the State Child Development Centre in Perth, Western Australia with ADHD, as defined by the Diagnostic and Statistical Manual of Mental Disorders (fourth edition) provided the study population. The control population consisted of 353 normal children with a history of allergy in whom radioallergosorbent (RAST) testing was being performed.
The prevalence of thyroid hormone abnormalities in the study population was 2.3% (95% CI 0.6%, 5.7%). There were no cases of generalized resistance to thyroid hormone. The prevalence of thyroid hormone abnormalities in the general population of children and adolescents has been reported to vary between 1 and 3.7%.
Routine thyroid hormone screening is not indicated in children with non-familial ADHD. 相似文献
Method:
Children attending the State Child Development Centre in Perth, Western Australia with ADHD, as defined by the Diagnostic and Statistical Manual of Mental Disorders (fourth edition) provided the study population. The control population consisted of 353 normal children with a history of allergy in whom radioallergosorbent (RAST) testing was being performed.
Results:
The prevalence of thyroid hormone abnormalities in the study population was 2.3% (95% CI 0.6%, 5.7%). There were no cases of generalized resistance to thyroid hormone. The prevalence of thyroid hormone abnormalities in the general population of children and adolescents has been reported to vary between 1 and 3.7%.
Conclusion:
Routine thyroid hormone screening is not indicated in children with non-familial ADHD. 相似文献
88.
JJ Rangasami DC Greenwood B McSporran PJ Smail CC Patterson NR Waugh 《Archives of disease in childhood》1997,77(3):210-213
OBJECTIVES: To calculate the incidence of type 1 diabetes in Scottish children aged less than 15 years between 1984 and 1993; to examine changes in incidence; and to calculate the prevalence of diabetes at the end of this period. DESIGN: Three data sources were used to construct the Scottish Study Group for the Care of Young Diabetics register: active reporting of all new cases; reports from the Scottish Morbidity Register 1; and local registers. SUBJECTS: All children resident in Scotland diagnosed with primary insulin dependent diabetes mellitus when less than 15 years of age between 1984 and 1993. MAIN OUTCOME MEASURES: Annual incidence and prevalence rate for Scotland; time trend in incidence over the 10 years; differences in incidence between the three different age groups; and completeness of the register. RESULTS: The average annual incidence for Scotland was 23.9/100,000 children. The prevalence rate was 1.5/1000 in 1993. A total of 2326 cases was identified from the three sources. Capture-recapture analysis suggests a case ascertainment of 98.6%. The annual incidence rates increased at a rate of 2% each year (rate ratio = 1.02, 95% confidence interval (CI) 1.01 to 1.03). The incidence was higher in boys than girls (rate ratio = 1.08, 95% CI 1.00 to 1.18), and the incidence rates increased with age: 15.3/100,000/year for age 0-4 years, 24.4/ 100,000/year for age 5-9 years, and 31.9/ 100,000/year for age 10-14 years. CONCLUSIONS: The incidence of type 1 diabetes in Scotland is increasing and the prevalence is relatively high. These findings have important implications for health service resource allocation. The Scottish Study Group for the Care of Young Diabetics' register provides a base for monitoring and research. 相似文献
89.
Auricular infections caused by high ear piercing in adolescents 总被引:1,自引:0,他引:1